Nomura Holdings
MRTX

Nomura Holdings’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Nomura Holdings’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-95,620
Closed -$3.56M – 1710
2023
Q1 		$3.56M Buy
95,620
+41,070
+75% +$1.85M 0.01% 660
2022
Q4 		$2.47M Buy
54,550
+27,827
+104% +$1.8M 0.01% 664
2022
Q3 		$1.87M Sell
26,723
-110,917
-81% -$8.21M 0.01% 826
2022
Q2 		$9.74M Buy
137,640
+115,601
+525% +$7.35M 0.03% 349
2022
Q1 		$1.88M Buy
+22,039
New +$2.25M 0.01% 905
2021
Q2 		– Sell
-4,500
Closed -$770K – 2407
2021
Q1 		$770K Buy
4,500
+3,294
+273% +$652K ﹤0.01% 1191
2020
Q4 		$265K Sell
1,206
-681
-36% -$147K ﹤0.01% 1348
2020
Q3 		$313K Sell
1,887
-1,613
-46% -$221K ﹤0.01% 1106
2020
Q2 		$399K Buy
+3,500
New +$339K ﹤0.01% 906

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Nomura Holdings's MRTX Position: Q2 2023 in Review

Nomura Holdings sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2023, closing a stake of 95,620 shares — an estimated $3.56M sold.

Nomura Holdings first reported a position in MRTX in Q2 2020 and held it in 9 quarters. The position peaked at $9.74M in Q2 2022. 207 funds tracked by Wall St. Rank hold MRTX as of Q2 2023.

  • Nomura Holdings reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Nomura Holdings sold 95,620 Mirati Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $3.56M.
  • Nomura Holdings first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
  • Nomura Holdings's Mirati Therapeutics, Inc. Common Stock position peaked at $9.74M in Q2 2022.
  • 207 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Nomura Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.